Stevanato Group S.p.A (STVN) Invested Capital (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Invested Capital of $150.2 million for Q1 2026, up 72.5% year-over-year from $87.1 million in Q1 2025, and down 71.72% quarter-over-quarter from $531.2 million in Q4 2025.
Stevanato Group S.p.A (STVN) Invested Capital (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Invested Capital for 7 consecutive years, with $150.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital rose 72.5% year-over-year to $150.2 million; the TTM figure through Mar 2026 stood at $866.7 million (up 26.74% YoY), while the FY2025 annual figure was $531.2 million, up 20.17% from the prior year.
- Invested Capital eased to $150.2 million in Q1 2026 per STVN's latest filing, from $531.2 million in the prior quarter.
- Across five years, Invested Capital topped out at $531.2 million in Q4 2025 and bottomed at $61.5 million in Q1 2022.
- Historically, Invested Capital has averaged $161.3 million across 5 years, with a median of $91.0 million in 2023.
- On a YoY basis, Invested Capital climbed as much as 484.5% in 2022 and fell as far as 33.08% in 2022.
- Stevanato Group S.p.A's Invested Capital stood at $203.2 million in 2022, then jumped by 100.82% to $408.1 million in 2023, then grew by 8.31% to $442.0 million in 2024, then grew by 20.17% to $531.2 million in 2025, then slumped by 71.72% to $150.2 million in 2026.
- Business Quant data shows STVN's Invested Capital at $150.2 million in Q1 2026, $531.2 million in Q4 2025, and $99.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 3.30 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 4.72 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 259.95 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 209.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 598.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 844.00 Mn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | 147.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 147.83 Mn |
| Mar 31, 2026 | 150.23 Mn |
| Dec 31, 2025 | 531.17 Mn |
| Sep 30, 2025 | 99.68 Mn |
| Jun 30, 2025 | 85.61 Mn |
| Mar 31, 2025 | 87.09 Mn |
| Dec 31, 2024 | 442.01 Mn |
| Sep 30, 2024 | 83.04 Mn |
| Jun 30, 2024 | 71.69 Mn |
| Mar 31, 2024 | 104.54 Mn |
| Dec 31, 2023 | 408.09 Mn |
| Sep 30, 2023 | 109.84 Mn |
| Jun 30, 2023 | 74.38 Mn |
| Mar 31, 2023 | 90.96 Mn |
| Dec 31, 2022 | 203.21 Mn |
| Sep 30, 2022 | 73.51 Mn |
| Jun 30, 2022 | 65.02 Mn |
| Mar 31, 2022 | 61.52 Mn |
| Dec 31, 2021 | -52.85 Mn |
| Sep 30, 2021 | 77.53 Mn |